Pioneering a New Approach to the Opioid Crisis. Atelerix Life Sciences Inc. is a newly-created Delaware C corporation organized to develop and commercialize a novel family of cutting-edge proprietary small molecules targeted at the fundamental processes of addiction. The initial focus is on the opioid crisis.